Fluoromount-G Anti-Fade

Product Overview

• Article Name: Fluoromount-G Anti-Fade
• Biozol Catalog Number: SBA-0100-35
• Supplier Catalog Number: 0100-35
• Alternative Catalog Number: SBA-0100-35
• Manufacturer: SouthernBiotech
• Category: Biochemikalien
• Application: ICC, IHC-Fr, IHC-P

Product Description

Fluoromount-G Anti-Fade is an aqueous-based compound for mounting slides used in microscopy applications in which the preservation of fluorescence intensity is critical. It is suitable for frozen and paraffin sections as well as cells.

Additional Information

• Description: Fluoromount-G® Anti-Fade is a non-hardening, aqueous-based compound for mounting slides used in microscopy applications in which the preservation of fluorescence intensity is critical. This mounting medium provides a semi-permanent seal for storage of slide preparations and since Fluoromount-G® Anti-Fade is water-soluble, the coverslip may be removed by submerging the slide in a PBS solution until the coverslip is loosened.
• Buffer Formulation: Glycerol containing anti-fade components and other proprietary ingredients
• Volume: 20.0 mL
• Storage & Handling: Store at 2-8°C
  Please refer to product specific SDS
• Applications: Immunohistochemistry-Frozen Sections
  Immunohistochemistry-Paraffin Sections
  Immunocytochemistry
• Recommended Dilutions: Please refer to product specific

Images

Paraffin embedded mouse small intestine tissue section was blocked with Normal Rabbit Serum (SB Cat. No. 0040-01) and stained with Goat Anti-Mouse IgA-UNLB (SB Cat. No. 1040-01) followed by Rabbit Anti-Goat IgG(H+L), Human SP ads-BIOT (SB Cat. No. 6164-08), Streptavidin-FITC (SB Cat. No. 7100-02), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).

Paraffin embedded mouse small intestine tissue section was blocked with Normal Rabbit Serum (SB Cat. No. 0040-01) and stained with Rat Anti-Mouse IgA-UNLB (SB Cat. No. 1165-01) followed by Rabbit Anti-Rat IgG(H+L), Human ads-BIOT (SB Cat. No. 6185-08), Streptavidin-FITC (SB Cat. No. 7100-02), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).

Paraffin embedded mouse small intestine tissue section was blocked with Normal Rabbit Serum (SB Cat. No. 0040-01) and stained with Rat Anti-Mouse IgA-UNLB (SB Cat. No. 1165-01) followed by Rabbit Anti-Rat IgG(H+L), Human ads-BIOT (SB Cat. No. 6185-08), Streptavidin-CY3 (SB Cat. No. 7100-12), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).

Paraffin embedded mouse small intestine tissue section was blocked with Normal Rabbit Serum (SB Cat. No. 0040-01) and stained with Rat Anti-Mouse IgA-UNLB (SB Cat. No. 1165-01) followed by Rabbit Anti-Rat IgG(H+L), Human ads-BIOT (SB Cat. No. 6185-08), Streptavidin-CY3.5 (SB Cat. No. 7100-24), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).

Human pancreatic carcinoma cell line MIA PaCa-2 was stained with Mouse Anti-Human CD44-BIOT (SB Cat. No. 9400-08; right) followed by Streptavidin-FITC (SB Cat. No. 7100-02), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).

Human pancreatic carcinoma cell line MIA PaCa-2 was stained with Mouse Anti-Human CD44-BIOT (SB Cat. No. 9400-08; right) followed by Streptavidin-TRITC (SB Cat. No. 7100-03), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).

Human pancreatic carcinoma cell line MIA PaCa-2 was stained with Mouse Anti-Human CD44-BIOT (SB Cat. No. 9400-08; right) followed by Streptavidin-TXRD (SB Cat. No. 7100-07), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).

Human pancreatic carcinoma cell line MIA PaCa-2 was stained with Mouse Anti-Human CD44-BIOT (SB Cat. No. 9400-08; right) followed by Streptavidin-CY3 (SB Cat. No. 7100-12), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).

Human pancreatic carcinoma cell line MIA PaCa-2 was stained with Mouse Anti-Human CD44-BIOT (SB Cat. No. 9400-08; right) followed by Streptavidin-CY2 (SB Cat. No. 7100-21), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).

Human pancreatic carcinoma cell line MIA PaCa-2 was stained with Mouse Anti-Human CD44-BIOT (SB Cat. No. 9400-08; right) followed by Streptavidin-CY3.5 (SB Cat. No. 7100-24), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).

Frozen newborn mouse cartilage sections were blocked with Normal Rabbit Serum (SB Cat. No. 0040-01) and stained with Mouse Anti-Collagen Type II-UNLB (right) followed by Rabbit F(ab')2 Anti-Mouse IgG(H+L), Human ads-BIOT (SB Cat. No. 6125-08), Streptavidin-FITC (SB Cat. No. 7100-02), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).

Frozen newborn mouse cartilage sections were blocked with Normal Rabbit Serum (SB Cat. No. 0040-01) and stained with Mouse Anti-Collagen Type II-UNLB (right) followed by Rabbit F(ab')2 Anti-Mouse IgG(H+L), Human ads-BIOT (SB Cat. No. 6125-08), Streptavidin-CY3 (SB Cat. No. 7100-12), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).

Frozen newborn mouse cartilage sections were blocked with Normal Rabbit Serum (SB Cat. No. 0040-01) and stained with Mouse Anti-Collagen Type II-UNLB (right) followed by Rabbit F(ab')2 Anti-Mouse IgG(H+L), Human ads-BIOT (SB Cat. No. 6125-08), Streptavidin-CY3.5 (SB Cat. No. 7100-24), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).

Frozen newborn mouse cartilage sections were blocked with Normal Rabbit Serum (SB Cat. No. 0040-01) and stained with Mouse Anti-Collagen Type II-UNLB (right) followed by Rabbit F(ab')2 Anti-Mouse IgG(H+L), Human ads-BIOT (SB Cat. No. 6125-08), Streptavidin-CY2 (SB Cat. No. 7100-21), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).

Human pancreatic carcinoma cell line MIA PaCa-2 was stained with Mouse Anti-Human CD44-UNLB (SB Cat. No. 9400-01) followed by Goat Anti-Mouse IgG, Human ads-AF488 (SB Cat. No. 1030-30).

Human pancreatic carcinoma cell line MIA PaCa-2 was stained with Mouse Anti-Human CD44-UNLB (SB Cat. No. 9400-01) followed by Goat Anti-Mouse IgG, Human ads-AF555 (SB Cat. No. 1030-32).

Human pancreatic carcinoma cell line MIA PaCa-2 was stained with Mouse Anti-Human CD44-UNLB (SB Cat. No. 9400-01) followed by Goat Anti-Mouse IgG, Human ads-BIOT (SB Cat. No. 1030-08) and Streptavidin-CY3.5 (SB Cat. No. 7100-24).

Human pancreatic carcinoma cell line MIA PaCa-2 was stained with Mouse Anti-Human CD44-UNLB (SB Cat. No. 9400-01) followed by Goat Anti-Mouse IgG, Human ads-BIOT (SB Cat. No. 1030-08) and Streptavidin-CY3 (SB Cat. No. 7100-12).

Human pancreatic carcinoma cell line MIA PaCa-2 was stained with DAPI.

Human pancreatic carcinoma cell line MIA PaCa-2 was stained with Mouse Anti-Human CD44-UNLB (SB Cat. No. 9400-01) followed by Goat Anti-Mouse IgG, Human ads-FITC (SB Cat. No. 1030-02).

Human pancreatic carcinoma cell line MIA PaCa-2 was stained with Mouse Anti-Human CD44-UNLB (SB Cat. No. 9400-01) followed by Goat Anti-Mouse IgG, Human ads-TXRD (SB Cat. No. 1030-07).

Human pancreatic carcinoma cell line MIA PaCa-2 was stained with Mouse Anti-Human CD44-UNLB (SB Cat. No. 9400-01) followed by Goat Anti-Mouse IgG, Human ads-TRITC (SB Cat. No. 1030-03).